Development of SARS-COV Therapeutics Using Quaternary Protein Mimetics

doi 10.32657/10356/41875
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

Nanyang Technological University

Related search

Angiotensin Receptor Blockers as Tentative SARS‐CoV‐2 Therapeutics

Drug Development Research
Drug Discovery
2020English

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights

2020English

Prior Immunization With Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected With SARS-CoV

Journal of Immunology
AllergyImmunology
2008English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2015English

Analysis of SARS-CoV-2-controlled Autophagy Reveals Spermidine, MK-2206, and Niclosamide as Putative Antiviral Therapeutics

2020English

SARS-CoV Nucleocapsid Protein Interacts With Cellular Pyruvate Kinase Protein and Inhibits Its Activity

Archives of Virology
MedicineVirology
2012English

Expression and Membrane Integration of SARS-CoV E Protein and Its Interaction With M Protein

Virus Genes
MedicineVirologyGeneticsMolecular Biology
2009English

In Silico Study of the Spike Protein From SARS-CoV-2 Interaction With ACE2: Similarity With SARS-CoV, Hot-Spot Analysis and Effect of the Receptor Polymorphism

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy